WHO ICTRP trial

Efficacy of Tamsulosin in relieving urinary symptoms due to JJ stent

CTRI/2014/08/004824 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2014/08/004824
Public title Efficacy of Tamsulosin in relieving urinary symptoms due to JJ stent
Scientific title Efficacy of Tamsulosin hydrochloride in relieving double j ureteral stent related morbidity-a randomized placebo controlled clinical study
Primary sponsor University College of Medical Sciences University of Delhi and GTB Hospital
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: null- Lower urinary tract symptoms Health Condition 2: N209- Urinary calculus, unspecified
Interventions Intervention1: Tamsulosin hydrochloride: Prescribed as Capsule 0.4 mgs at to be taken orally at bed time after meals once daily with sips of water for four weeks. Control Intervention1: Lactobacillus: Prescribed as one capsule lactobacillus…
Registration date May 8, 2014
Target size 60
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations